NanoViricides
NNVC
#10521
Rank
โ‚น3.40 B
Marketcap
โ‚น133.36
Share price
6.77%
Change (1 day)
-10.46%
Change (1 year)

NanoViricides (NNVC) - Net assets

Net assets on the balance sheet as of June 2026 : โ‚น0.81 Billion

According to NanoViricides's latest financial reports the company has โ‚น0.81 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

NanoViricides - Net assets on balance sheet (from 2006 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$โ‚น1.21 B-33.07%
2022-06-30$โ‚น1.82 B-18.07%
2021-06-30$โ‚น2.22 B34.97%
2020-06-30$โ‚น1.64 B125.53%
2019-06-30$โ‚น0.73 B-39.56%
2018-06-30$โ‚น1.20 B-7.93%
2017-06-30$โ‚น1.31 B-15.59%
2016-06-30$โ‚น1.55 B-23.03%
2015-06-30$โ‚น2.02 B44.23%
2014-06-30$โ‚น1.40 B193.94%
2013-06-30$โ‚น0.47 B-37.99%
2012-06-30$โ‚น0.76 B69.52%
2011-06-30$โ‚น0.45 B49.92%
2010-06-30$โ‚น0.30 B154.36%
2009-06-30$โ‚น0.11 B524.5%
2008-06-30$โ‚น19.04 M-6.09%
2007-06-30$โ‚น20.27 M-64.66%
2006-06-30$โ‚น57.38 M-2098.7%
2005-06-30$-โ‚น2.88 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
โ‚น1.102 T 135,154.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น3.943 T 483,425.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น2.198 T 269,441.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น2.287 T 280,405.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น17.92 Billion-2,296.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น42.67 Billion-5,332.00%๐Ÿ‡บ๐Ÿ‡ธ USA